Manufacturing

Articles

Repligen and Navigo’s novel ligand could be the first to address antibody aggregation in low pH elution buffers.

Repligen and Navigo GmbH Launch Industry-First Protein A Ligand for Purification of pH-Sensitive Antibodies

AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.

AGC Bio Boosts Manufacturing Capacity for pDNA and mRNA at Heidelberg Facility

Nirupama (Rupa) Pike, PhD, is director of Enterprise Science and Innovation Partnerships at Thermo Fisher Scientific.

The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows. 

Reevaluating Cell and Gene Therapy Development

Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.

Corning’s New Cell and Gene Therapy Platform Demonstrates Large-Scale Bioproduction

The collaboration will focus on the interactions between WTX-124 indukine and KEYTRUDA (pembrolizumab).

Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck

Artiva Biotherapeutics’s new R&D and GMP manufacturing center in San Diego, Calif., for NK cell therapies is expected to open in 2022.

Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

Lykan Bioscience and Vineti will combine their capabilities to streamline process development and manufacturing to move cell therapies through clinical phases to commercialization.

Lykan Bioscience and Vineti Partner to Advance Cell Therapies from Clinic to Commercialization

Lonza and Sheba Medical Center have successfully dosed four patients with a CD19 autologous CAR-T cell therapy using Lonza’s Cocoon automated manufacturing platform.

Lonza and Sheba Medical Center Demonstrate Successful Cell Therapy Results with Cocoon Automated Platform

AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.

AGC Biologics Acquires Cell and Gene Therapy Commercial Manufacturing Facility

Catalent finalizes their acquisition of iPSC developer and manufacturer RheinCell Therapeutics.

Manufacturing, Cell Therapies